Notable ETF Outflow Detected - PPH, NVS, SNY, NVO

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Pharmaceutical ETF ( PPH) where we have detected an approximate $24.2 million dollar outflow -- that's a 7.3% decrease week over week (from 5,488,138 to 5,088,138). Among the largest underlying components of PPH, in trading today Novartis ( NVS) is up about 0.2%, Sanofi ( SNY) is up about 1.8%, and Novo-Nordisk A/S ( NVO) is lower by about 1.7%. For a complete list of holdings, visit the PPH Holdings page »

Click here to find out which 9 other ETFs experienced notable outflows »

The chart below shows the one year price performance of PPH, versus its 200 day moving average:

Pharmaceutical ETF 200 Day Moving Average Chart

Looking at the chart above, PPH's low point in its 52 week range is $46.34 per share, with $62.89 as the 52 week high point — that compares with a last trade of $60.82. Comparing the most recent share price to the 200 day moving average can also be a useful technical analysis technique -- learn more about the 200 day moving average ».

Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded back and forth just like stocks, but can also be created or destroyed to accommodate investor demand. Each week we monitor the week-over-week change in shares outstanding data, to keep a lookout for those ETFs experiencing notable inflows (many new units created) or outflows (many old units destroyed). Creation of new units will mean the underlying holdings of the ETF need to be purchased, while destruction of units involves selling underlying holdings, so large flows can also impact the individual components held within ETFs.

If you liked this article you might like

5 ETFs to Buy If You Love Johnson & Johnson's First-Quarter Earnings

3 Must-Watch Economic Indicators for the Summer

The Trader Daily: Valeant's Crash Scatters Debris

The Trader Daily: Valeant's Crash Scatters Debris

Why Now May Be the Time for a Dose of Pharmaceutical Stocks

Biotech and Pharmaceutical Stocks Look Sick, Creating Problems for Stock Market